跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 91,203 条关于
“Alzheimer's disease agitation”
全部
91,203
临床试验
68,456
药物
1,428
机构
173
资讯
21,146
4个月前
FDA Approves Auvelity for Alzheimer's Disease Agitation, Marking Second Approved Treatment Option
去年
Axsome's AXS-05 Shows Promise in Alzheimer's Agitation Trials, NDA Submission Planned for 2025
8个月前
Axsome Therapeutics Receives FDA Priority Review for AXS-05 in Alzheimer's Disease Agitation
去年
Axsome Submits FDA Application for AXS-05 in Alzheimer's Disease Agitation Following Positive Phase 3 Results
去年
THC Shows Promise in Managing Agitation in Alzheimer's Disease, CTAD Trial Reports
去年
AXS-05, a Novel NMDA Receptor Antagonist, Shows Promise for Agitation in Alzheimer's Disease
8个月前
Neumora's NMRA-511 Shows Clinically Meaningful Results in Phase 1b Alzheimer's Agitation Study
2年前
IGC Pharma Expands CALMA Phase 2 Trial for Alzheimer's Agitation Treatment with New Oklahoma Site
去年
Novel NMDA Inhibitor AXS-05 Shows Promise for Alzheimer's Agitation Without Antipsychotic Risks
去年
IGC Pharma Reports Promising Interim Results for Alzheimer's Agitation Therapy
第 1 页，共 2115 页
上一页
下一页
